Here's Why Keryx Biopharmaceuticals and Akebia Therapeutics Are Plunging Today [The Motley Fool]
Akebia Therapeutics, Inc. (AKBA)
Last akebia therapeutics, inc. earnings: 3/10 07:49 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akebia.com/investor-relations
Company Research
Source: The Motley Fool
Shares of both companies tumble after the two entities announced the signing of a merger agreement. Here's what investors need to know. Brian Feroldi ( TMFTypeoh ) Jun 28, 2018 at 11:21AM What happened In response to the companies signing a merger agreement, shares of Akebia Therapeutics ( NASDAQ:AKBA ) and Keryx Biopharmaceuticals ( NASDAQ:KERX ) fell 18% and 12%, respectively, as of 10:47 a.m. EDT on Thursday. So what Akebia Therapeutics and Keryx Biopharmaceuticals announced today that they have signed an agreement to merge. Here are the details that investors need to know: This deal will be an all-stock transaction. The newly created company will be called Akebia Therapeutics, Inc. Keryx shareholders will receive 0.37433 shares of the newly formed company for each share currently owned. Akebia's current president and
Show less
Read more
Impact Snapshot
Event Time:
AKBA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKBA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKBA alerts
High impacting Akebia Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AKBA
News
- Akebia Therapeutics, Inc. (NASDAQ: AKBA) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management [Seeking Alpha]Seeking Alpha
- Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- Thinking about buying stock in Akebia Therapeutics, Mind Medicine, ATAI Life Sciences, Doma Holdings, or Iterum Therapeutics?PR Newswire
AKBA
Earnings
- 3/14/24 - Beat
AKBA
Sec Filings
- 4/16/24 - Form 8-K
- 3/28/24 - Form 8-K
- 3/15/24 - Form 8-K
- AKBA's page on the SEC website